Literature DB >> 12111355

Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain.

Yuki Okada1, Hirofumi Sawa, Shuichi Endo, Yasuko Orba, Takashi Umemura, Hiroshi Nishihara, Alexandru C Stan, Shinya Tanaka, Hidehiro Takahashi, Kazuo Nagashima.   

Abstract

To examine the function of JC virus (JCV) agnoprotein, we examined the brains of cases of progressive multifocal leukoencephalopathy (PML), which is caused by JCV infection, using a newly generated antibody. The antibody reacted with 8 kDa protein specific for JCV agnoprotein by Western blotting. In vitro analyses showed that JCV capsid protein VP1 and large T antigen (T-Ag) were localized in the nuclei, but that agnoprotein was mainly detected in the cytoplasm of JCV-infected cells with an occasional nuclear staining. In the PML brain, an immunoreactive signal for agnoprotein was distributed in the perinuclear areas and cytoplasmic processes with occasional punctate staining in demyelinating lesions as well as adjacent myelinated areas. Agnoprotein presented mostly in the infected oligodendrocytes and partly in the astrocytes. Using double immunostaining, agnoprotein was seen to be expressed in the cytoplasmic processes of the cells, the nuclei of which were labeled with VP1 and T-Ag, where virus particles existed. Thus, JCV agnoprotein was mostly expressed in the infected oligodendrocytes and mainly localized in the cytoplasmic processes apart from virus particles in the demyelinated lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111355     DOI: 10.1007/s00401-002-0526-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Authors:  Nobuo Sanjo; Yurie Nose; Yukiko Shishido-Hara; Saneyuki Mizutani; Yoshiki Sekijima; Hitoshi Aizawa; Toru Tanizawa; Takanori Yokota
Journal:  J Neurol       Date:  2018-12-03       Impact factor: 4.849

2.  Negative association of Epstein-Barr virus or herpes simplex virus-1 with tumefactive central nervous system inflammatory demyelinating disease.

Authors:  Takao Kiriyama; Hiroshi Kataoka; Takahiko Kasai; Akitaka Nonomura; Satoshi Ueno
Journal:  J Neurovirol       Date:  2010-11-11       Impact factor: 2.643

Review 3.  Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

Authors:  Martyn K White; Ilker K Sariyer; Jennifer Gordon; Serena Delbue; Valeria Pietropaolo; Joseph R Berger; Kamel Khalili
Journal:  Rev Med Virol       Date:  2015-12-14       Impact factor: 6.989

4.  The agnoprotein of polyomavirus JC is released by infected cells: evidence for its cellular uptake by uninfected neighboring cells.

Authors:  Onder Otlu; Francesca Isabella De Simone; Yolanda-Lopez Otalora; Kamel Khalili; Ilker Kudret Sariyer
Journal:  Virology       Date:  2014-08-23       Impact factor: 3.616

Review 5.  Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40.

Authors:  A Sami Saribas; Pascale Coric; Serge Bouaziz; Mahmut Safak
Journal:  J Cell Physiol       Date:  2018-11-02       Impact factor: 6.384

6.  Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.

Authors:  Dorota Kaniowska; Rafal Kaminski; Shohreh Amini; Sujatha Radhakrishnan; Jay Rappaport; Edward Johnson; Kamel Khalili; Luis Del Valle; Armine Darbinyan
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 7.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling.

Authors:  Yasuko Orba; Tadaki Suzuki; Yoshinori Makino; Kanako Kubota; Shinya Tanaka; Takashi Kimura; Hirofumi Sawa
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

9.  The human polyoma JC virus agnoprotein acts as a viroporin.

Authors:  Tadaki Suzuki; Yasuko Orba; Yuki Okada; Yuji Sunden; Takashi Kimura; Shinya Tanaka; Kazuo Nagashima; William W Hall; Hirofumi Sawa
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

10.  Inhibition of virus production in JC virus-infected cells by postinfection RNA interference.

Authors:  Yasuko Orba; Hirofumi Sawa; Hiroshi Iwata; Shinya Tanaka; Kazuo Nagashima
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.